|
Analysis/device evaluation: upon receipt of the sample, visual examination was performed over the entire length of the catheter, which revealed heavy dry blood residue within the inflation lumen.The proximal area of the balloon was severely wrinkled and the middle of the balloon was bulged.Under 10-30x magnification, a longitudinal rupture was identified in the middle of the balloon, approximately 38 mm from distal tip of the catheter.The longitudinal rupture was 6 mm long and was found under a folded area of the balloon.Due to the heavy dry blood residue, functional testing was unable to be performed.A lot history review revealed there are no similar complaints associated with material rupture for this lot.A device history record (dhr) review was performed and noted the device was manufactured to specification prior to being released for distribution.There was nothing found to indicate there was a manufacturing related cause for this event.Conclusion: returned product analysis confirmed the material rupture was longitudinal in nature and was 6 mm long in the middle of the balloon.There was nothing found to indicate there was a manufacturing related cause for this event.A definitive root cause for the rupture could not be determined.It is unknown if procedural issues contributed to the reported event.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
|
|
It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly ruptured prior to inflation.The health care professional (hcp) used a contralateral approach through the right common femoral artery to treat the target lesion in the left superficial femoral artery (sfa).The hcp predilated the target lesion prior to the lutonix dcb treatment.The hcp advanced the lutonix dcb to the target lesion, under negative pressure.The hcp reported blood infiltrating the endoflator prior to inflating the lutonix dcb, which the hcp believed indicates a "hole" was present in the balloon.The lutonix dcb was removed intact and another lutonix dcb was used to complete the procedure.Although requested, the target lesion and vessel morphology are unknown.The lutonix dcb was returned for evaluation.No adverse patient outcomes were reported.
|